J & J may nab surgical robotics company Auris Health
Johnson & Johnson (NYSE:JNJ) intends to acquire surgical robotics company Auris Health, according to a report by Bloomberg News.
In May 2018, Auris inked an agreement with J&J’s division Ethicon’s NeuWave Medical subsidiary to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions. J&J has been working with Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences on Verb Surgical’s prototype robot-assisted surgery platform.
J&J wants to spend more for Auris than the smaller company’s $2 billion valuation from its latest funding round, the Bloomberg report said...
Source: Mass Device - January 23, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Endoscopic / Arthroscopic Mergers & Acquisitions Robotics aurishealth johnsonandjohnson Source Type: news
Olympus announces Spiration bronchial valve launch
The Spiration valve is an umbrella-shaped device that a health provider places in a targeted airway of the lung during a short bronchoscopic procedure. [Image courtesy of Olympus]Olympus’ Spiration bronchial valve for the treatment of severe emphysema is now available on the market, the company (TYO:7733) said today.
The announcement came a little over a year after FDA approval of Spiration, which was designated as a breakthrough medical device. Spiration also has regulatory approval in the E.U., Australia and New Zealand.
Get the full story on our sister site Medical Design & Outsourcing.
The post Olymp...
Source: Mass Device - January 22, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News News Well emphysema Olympus Source Type: news
Penn Highlands Healthcare first in the region to offer first FDA-approved lung valve for patients with severe COPD/emphysema
(Pulmonx) Penn Highlands Healthcare is the first medical facility in the region to offer bronchoscopic lung volume reduction using the first lung valve approved by the US Food and Drug Administration for helping emphysema patients breathe easier without major surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news
Foreign body aspiration of the lower airways in children - diagnosis in clinical practice - Hajnal D, Kov ács T.
INTRODUCTION AND AIM: Rigid bronchoscopic foreign body removal is the gold standard procedure for foreign body aspiration. We have analysed our results of bronchoscopies and the accuracy of diagnosis among the paediatric population in Southeast Hungary. ... (Source: SafetyLit)
Source: SafetyLit - December 19, 2018 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
National Institute for Health and Care Excellence (NICE) issues new guidelines for COPD
(Pulmonx) NICE makes a 'strong' recommendation that patients with severe COPD be referred for evaluation for bronchoscopic lung volume reduction, including the Zephyr ® Endobronchial Valve System.NICE has broadened the criteria for evaluation and a new group of people for whom lung volume reduction surgery was unsuitable may now be evaluated for treatment with Zephyr Valves, a less invasive treatment option. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2018 Category: International Medicine & Public Health Source Type: news
Olympus wins FDA nod for Spiration bronchial valve
Olympus (TYO:7733) said yesterday that it won FDA approval for its Spiration Valve System intended to treat severe emphysema, which was designated as a breakthrough medical device.
The Spiration Valve is an umbrella shaped device intended to improve breathing by blocking airflow to diseased portions of the lung, the Tokyo-based company said. The device is placed during a bronchoscopic procedure to reduce lung volume in diseased lung sections and allow healthier tissue in the remaining portion of the lung to function better.
Approval of the device came based on the results from the Emprove clinical trial of the SVS, which...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Olympus Source Type: news
Auris Scores Big with $200M Raise for Robotics Platform
The robotics market is surging. Auris Health recent raise of $200 million to commercialize the Monarch Platform is a perfect example. The Redwood City, CA-based company has raised more than $700 million to develop and commercialize the Monarch platform - a robotic system that enables more-accurate diagnosis and treatment of small and hard-to-reach nodules in the periphery of the lung.
Monarch received FDA clearance for Monarch to perform diagnostic and therapeutic bronchoscopic procedures earlier this year. The platform uses a familiar controller interface to navigate a flexible robotic endoscope to the periphery of the lu...
Source: MDDI - November 30, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Auris Health closes $220m equity funding round
Auris Health said today that it closed a $220 million equity financing round to help support its next-generation Monarch robotic interventional platform.
The Redwood City, Calif.-based company said that the round was led by Partner Fund Management and joined by newly invested Wellington Management, D1 Capital Partners and Senator Investment Group and existing investors Mithril Capital, Lux Capital and Viking Global Investors.
The funding round brings the total raised for its Monarch surgical platform up to $700 million, Auris Health said.
“The support of this group of world-class investors will be instrumental as Aur...
Source: Mass Device - November 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Robotics Wall Street Beat aurishealth Source Type: news
Pulmonx wins Aetna coverage for Zephyr endobronchial valve
Pulmonx said yesterday that it won national coverage through health insurer Aetna for its Zephyr endobronchial valve system intended for treating severe emphysema and chronic obstructive pulmonary disorder.
The coverage will make the Zephyr valve available to Aetna’s 22 million members, the Redwood City, Calif.-based company said.
Under its new policy, Aetna specifically named the Zephyr as an approved bronchoscopic option for lung volume reduction, considering it medically necessary for the broncoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung with littl...
Source: Mass Device - November 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Respiratory Pulmonx Source Type: news
Bronchoscopy
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 22, 2018 Category: General Medicine Source Type: news
Auris Health touts robotically-assisted bronchoscopy study results
Auris Health’s Monarch bronchoscopy platform reached lung nodules and biopsied tissue with “high accuracy” in a recent study, according to the company.
Eight investigators performed robotic-assisted bronchoscopy procedures using the Monarch platform on a cadaveric model designed to mimic a real-life bronchoscopy procedure. Sixty-seven simulated tumor targets one to three centimeters in size were prepared in eight human cadaveric lungs. The tissue acquired during the bronchoscopy was evaluated and correctly identified as the implanted target in 97% of cases, the study noted. Auris presented the results of ...
Source: Mass Device - October 15, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Featured Oncology Robotics aurishealth johnsonandjohnson Source Type: news
Finding Lung Cancer Outside the Airways Just Got Easier
Diagnosing solitary lung tumors located outside of a patient's main airways has long been a challenge, but evidence is building around a technology designed to improve access to such tumors.
According to data unveiled this week at the European Respiratory Society International Congress in Paris, Broncus Medical's Archimedes virtual bronchoscopy navigation system helped to more than double the diagnostic yield for nodules with negative bronchus sign or an airway leading to the nodule.
The six-year-old, San Jose, CA-based company said the Archimedes System is the only system of its kind offering real-...
Source: MDDI - September 17, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Source Type: news
New Bronchoscopic Option Used for Severe Emphysema
First bronchoscopic lung volume reduction using endobronchial valve performed at Temple University (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 10, 2018 Category: Respiratory Medicine Tags: Pulmonology, Surgery, Institutional, Source Type: news
New Bronchoscopic Option Used for Severe Emphysema
MONDAY, Sept. 10, 2018 -- Temple University Hospital has become the first center in the U.S. to perform bronchoscopic lung volume reduction using implantation of the Zephyr Endobronchial Valve (Zephyr EBV) to treat hyperinflation associated with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2018 Category: Pharmaceuticals Source Type: news
Body Vision raises $8.5 million to market cancer diagnostic system in U.S.
Body Vision Medical said today it has landed $8.5 million in funding to accelerate the commercialization of its LungVision lung navigation system in the U.S. and to extend its product line.
The Ramat Ha Sharon, Israel-based company specializes in lung cancer diagnostics through augmented real-time intra-body navigation and imaging. Its catheter is designed for use in conjunction with standard bronchoscopes and its LungVision system for guiding endotherapy accessories to small pulmonary nodules. LungVision’s catheter won FDA clearance in April. Its imaging and navigation system was cleared in May 2017.
“Today...
Source: Mass Device - September 5, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Catheters Diagnostics Oncology Body Vision Medical Source Type: news
